• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

J Biomol Tech . Initial Evaluation of a Mobile SARS-CoV-2 RT-LAMP Testing Strategy

tetano

Editor, Senior Moderator
J Biomol Tech


. 2021 Sep;32(3):137-147.
doi: 10.7171/jbt.21-32-03-009.
Initial Evaluation of a Mobile SARS-CoV-2 RT-LAMP Testing Strategy


Christina M Newman[SUP] 1 [/SUP], Mitchell D Ramuta[SUP] 1 [/SUP], Matthew T McLaughlin[SUP] 1 [/SUP], Roger W Wiseman[SUP] 1 [/SUP], Julie A Karl[SUP] 1 [/SUP], Dawn M Dudley[SUP] 1 [/SUP], Miranda R Stauss[SUP] 2 [/SUP], Robert J Maddox[SUP] 2 [/SUP], Andrea M Weiler[SUP] 2 [/SUP], Mason I Bliss[SUP] 3 [/SUP], Katrina N Fauser[SUP] 2 [/SUP], Luis A Haddock 3rd[SUP] 3 [/SUP], Cecilia G Shortreed[SUP] 1 [/SUP], Amelia K Haj[SUP] 1 [/SUP], Molly A Accola[SUP] 4 [/SUP], Anna S Heffron[SUP] 1 [/SUP], Hailey E Bussan[SUP] 1 [/SUP], Matthew R Reynolds[SUP] 3 2 [/SUP], Olivia E Harwood[SUP] 1 [/SUP], Ryan V Moriarty[SUP] 1 [/SUP], Laurel M Stewart[SUP] 1 [/SUP], Chelsea M Crooks[SUP] 3 [/SUP], Trent M Prall[SUP] 1 [/SUP], Emma K Neumann[SUP] 1 [/SUP], Elizabeth D Somsen[SUP] 1 [/SUP], Corrie B Burmeister[SUP] 1 [/SUP], Kristi L Hall[SUP] 1 [/SUP], William M Rehrauer[SUP] 1 4 [/SUP], Thomas C Friedrich[SUP] 3 2 [/SUP], Shelby L O'Connor[SUP] 1 2 [/SUP], David H O'Connor[SUP] 1 2 [/SUP]



Affiliations

Abstract

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) control in the United States remains hampered, in part, by testing limitations. We evaluated a simple, outdoor, mobile, colorimetric reverse-transcription loop-mediated isothermal amplification (RT-LAMP) assay workflow where self-collected saliva is tested for SARS-CoV-2 RNA. From July 16, 2020, to November 19, 2020, surveillance samples (n = 4704) were collected from volunteers and tested for SARS-CoV-2 at 5 sites. Twenty-one samples tested positive for SARS-CoV-2 by RT-LAMP; 12 were confirmed positive by subsequent quantitative reverse-transcription polymerase chain reaction (qRT-PCR) testing, whereas 8 tested negative for SARS-CoV-2 RNA, and 1 could not be confirmed because the donor did not consent to further molecular testing. We estimated the false-negative rate of the RT-LAMP assay only from July 16, 2020, to September 17, 2020 by pooling residual heat-inactivated saliva that was unambiguously negative by RT-LAMP into groups of 6 or fewer and testing for SARS-CoV-2 RNA by qRT-PCR. We observed a 98.8% concordance between the RT-LAMP and qRT-PCR assays, with only 5 of 421 RT-LAMP-negative pools (2493 total samples) testing positive in the more-sensitive qRT-PCR assay. Overall, we demonstrate a rapid testing method that can be implemented outside the traditional laboratory setting by individuals with basic molecular biology skills and that can effectively identify asymptomatic individuals who would not typically meet the criteria for symptom-based testing modalities.

Keywords: colorimetric LAMP; point-of-care test; saliva-based.
 
Back
Top Bottom